KEITH D. TAYLOR - 16 Jan 2024 Form 4 Insider Report for EQUINIX INC (EQIX)

Signature
/s/ Samantha Lagocki, POA
Issuer symbol
EQIX
Transactions as of
16 Jan 2024
Net transactions value
-$2,626,150
Form type
4
Filing time
18 Jan 2024, 16:56:13 UTC
Previous filing
06 Nov 2023
Next filing
14 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EQIX Common Stock Options Exercise $0 +1,661 +8.7% $0.000000 20,838 16 Jan 2024 Direct
transaction EQIX Common Stock Options Exercise $0 +1,311 +6.3% $0.000000 22,149 16 Jan 2024 Direct
transaction EQIX Common Stock Options Exercise $0 +1,504 +6.8% $0.000000 23,653 16 Jan 2024 Direct
transaction EQIX Common Stock Options Exercise $0 +1,784 +7.5% $0.000000 25,437 16 Jan 2024 Direct
transaction EQIX Common Stock Sale $79,096 -100 -0.39% $790.96 25,337 17 Jan 2024 Direct F1, F2
transaction EQIX Common Stock Sale $496,442 -626 -2.5% $793.04 24,711 17 Jan 2024 Direct F1, F3
transaction EQIX Common Stock Sale $302,009 -380 -1.5% $794.76 24,331 17 Jan 2024 Direct F1, F4
transaction EQIX Common Stock Sale $377,360 -474 -1.9% $796.12 23,857 17 Jan 2024 Direct F1, F5
transaction EQIX Common Stock Sale $159,421 -200 -0.84% $797.10 23,657 17 Jan 2024 Direct F1, F6
transaction EQIX Common Stock Sale $160,378 -200 -0.85% $801.89 23,457 17 Jan 2024 Direct F1
transaction EQIX Common Stock Sale $160,996 -200 -0.85% $804.98 23,257 17 Jan 2024 Direct F1, F7
transaction EQIX Common Stock Sale $80,575 -100 -0.43% $805.75 23,157 17 Jan 2024 Direct F1
transaction EQIX Common Stock Sale $323,304 -400 -1.7% $808.26 22,757 17 Jan 2024 Direct F1, F8
transaction EQIX Common Stock Sale $161,892 -200 -0.88% $809.46 22,557 17 Jan 2024 Direct F1, F9
transaction EQIX Common Stock Sale $162,118 -200 -0.89% $810.59 22,357 17 Jan 2024 Direct F1, F10
transaction EQIX Common Stock Sale $162,560 -200 -0.89% $812.80 22,157 17 Jan 2024 Direct F1, F11

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EQIX Restricted Stock Units Award $0 +1,661 $0.000000 1,661 16 Jan 2024 Common Stock 1,661 $0.000000 Direct F12, F13
transaction EQIX Restricted Stock Units Options Exercise $0 -1,661 -100% $0.000000* 0 16 Jan 2024 Common Stock 1,661 $0.000000 Direct F12, F13
transaction EQIX Restricted Stock Units Options Exercise $0 -1,311 -100% $0.000000* 0 16 Jan 2024 Common Stock 1,311 $0.000000 Direct F13, F14
transaction EQIX Restricted Stock Unit Options Exercise $0 -1,504 -50% $0.000000 1,503 16 Jan 2024 Common Stock 1,504 $0.000000 Direct F13, F15
transaction EQIX Restricted Stock Unit Options Exercise $0 -1,784 -33% $0.000000 3,565 16 Jan 2024 Common Stock 1,784 $0.000000 Direct F13, F16
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares were sold pursuant to a 10b5-1 Trading Plan in order to raise funds to pay the required withholding tax pursuant to the vesting of RSUs.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $790.95 to $790.97, inclusive. The reporting person undertakes to provide to Equinix, Inc, any security holder of Equinix Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 through 11 to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $792.95 to $793.79 inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $794.46 to $795.29 inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $795.84 to $796.69 inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $797.08 to $797.13 inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $804.57 to $805.39 inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $807.89 to $808.47 inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $809.11 to $809.81 inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $810.27 to $810.91 inclusive.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $812.61 to $812.99 inclusive.
F12 On February 18, 2021, the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the degree to which a relative Total Shareholder Return target was attained for the period January 1, 2021 to December 31, 2023. The Compensation Committee certified that the payout for this award would be 84.44% (out of a possible 100%) of the target to the reporting person based on the degree to which Equinix performed against the Russell 1000 Index.
F13 Restricted stock unit award expires upon reporting person's termination of service.
F14 Vesting is dependent upon continuous active service as an employee, consultant or director of the Company or a subsidiary of the Company (Service) throughout the vesting period. The Restricted Stock Units shall vest as follows: 33.33% of the RSUs vested on January 15, 2022 and an additional 33.33% of the RSUs will each vest on January 15, 2023 and January 15, 2024.
F15 Vesting is dependent upon continuous active service as an employee, consultant or director of the Company or a subsidiary of the Company (Service) throughout the vesting period. The Restricted Stock Units shall vest as follows: 33.33% of the RSUs vested on January 15, 2023 and an additional 33.33% of the RSUs will each vest on January 15, 2024 and January 15, 2025.
F16 Vesting is dependent upon continuous active service as an employee, consultant or director of the Company or a subsidiary of the Company (Service) throughout the vesting period. The Restricted Stock Units shall vest as follows: 33.33% of the RSUs vested on January 15, 2024 and an additional 33.33% of the RSUs will each vest on January 15, 2025 and January 15, 2026.